Table 1 Clinical and laboratory characteristics of the study group (27 patients)
Frequency | Percent | |
|---|---|---|
Laboratory data | ||
CBC parameters | ||
Anemia | 17 | 63.00 |
Thrombocytopenia < 150 × 103 | 6 | 22.20 |
Leukocytosis | 16 | 59.30 |
Lymphopenia < 1000/ccm3 | 14 | 51.90 |
Hypernatremia > 45 mEq/L | 14 | 51.90 |
K disturbances | ||
Low | 6 | 22.20 |
High | 10 | 37.00 |
Metabolic acidosis (ph < 7.2) | 12 | 44.40 |
High CRP > 5 mg/dl | 27 | 100.00 |
High ferritin > 200 mg/dl) | 27 | 100.00 |
High d- dimer > 500 mg/dl | 17 | 63.00 |
Coagulopathy (INR > 1.2) | 13 | 48.10 |
High troponin I (> 100 pg/mI) | 6 | 22.20 |
Complications | ||
Pneumonia | 18 | 66.70 |
ARDS | 5 | 18.50 |
AKI (eGFR < 60 ml/min/m2) | 10 | 37.00 |
Myocarditis | 6 | 22.20 |
Medications | ||
Vasoactive infusion | 8 | 29.60 |
Antibiotics | 26 | 96.30 |
Corticosteroids | 22 | 81.50 |
Anticoagulants | 14 | 51.80 |
Antiplatelets | 17 | 63.00 |
Remdesivir | 1 | 4.00 |
IVIG | 4 | 14.80 |
Outcomes | ||
Discharge | 23 | 85.20 |
Mortality | 4 | 14.80 |